Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-Letters: Submit a response to the article
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (7)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Nadeson, R.
Right arrow Articles by Goodchild, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nadeson, R.
Right arrow Articles by Goodchild, C. S.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

British Journal of Anaesthesia, 2002, Vol. 88, No. 5 685-691
© 2002 The Board of Management and Trustees of the British Journal of Anaesthesia

Laboratory Investigations

Potentiation by ketamine of fentanyl antinociception. I. An experimental study in rats showing that ketamine administered by non-spinal routes targets spinal cord antinociceptive systems

R. Nadeson, A. Tucker, E. Bajunaki and C. S. Goodchild*

Monash University Department of Anaesthesia, Level 5, Block E, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria, Australia 3168*Corresponding author

Background. Ketamine has been found to exert antinociceptive effects in animals and to be analgesic at subanaesthetic doses in humans. This study was designed to investigate the involvement of spinal cord mechanisms in the potentiation of opioid analgesia by parenteral non-spinal administration of ketamine.

Methods. Thresholds for nociception were measured in an acute pain model in rats that allowed identification of antinociceptive effects due to drug action in the spinal cord. Dose–response curves for the antinociceptive effects of ketamine alone and ketamine in conjunction with the µ opioid fentanyl were constructed.

Results. Intraperitoneal ketamine up to 3.75 mg kg–1 caused no sedative or antinociceptive effects and intrathecal ketamine caused dose-dependent, spinally mediated antinociceptive effects. Injections of ketamine doses that caused no antinociceptive effects when given alone (intrathecal 25 µg and intraperitoneal 3.75 mg/kg) significantly increased spinally mediated antinociception produced by intrathecal fentanyl injections when assessed using noxious heat (tail-flick test) but not when assessed by noxious electrical current (electrical current threshold test).

Conclusions. We conclude that ketamine can potentiate the effects of fentanyl by an interaction at the level of the spinal cord even when ketamine is given via a non-spinal route of administration.

Br J Anaesth 2002; 88: 685–91


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
S. P. Cohen, A. S. Chang, T. Larkin, and J. Mao
The Intravenous Ketamine Test: A Predictive Response Tool for Oral Dextromethorphan Treatment in Neuropathic Pain
Anesth. Analg., December 1, 2004; 99(6): 1753 - 1759.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
M.-A. Docquier, P. Lavand'homme, V. Boulanger, V. Collet, and M. De Kock
Questioning the cardiocirculatory excitatory effects of opioids under volatile anaesthesia
Br. J. Anaesth., September 1, 2004; 93(3): 408 - 413.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.